A novel risk factor for predicting anti-tuberculosis drug resistance in patients with tuberculosis complicated with type 2 diabetes mellitus
The world strives for progress towards accelerating the decline rate of tuberculosis (TB) incidence from 2% to 10% per year to reach the 2035 milestone of the End TB Strategy (WHO 2014). However, the appearance and growing incidence of drug-resistant TB impedes this progress largely. WHO estimated that in 2018, there were 484000 new cases with resistance to rifampicin (the most effective first-line drug) and 78% of these cases were multidrug-resistant TB (MDR-TB) (WHO 2019). Early and accurate diagnosis is of utmost importance to mitigate burden brought by MDR-TB (WHO 2010).
Bayer's finerenone meets primary endpoint in Phase III FIDELIO-DKD renal outcomes study in patients with chronic kidney disease and type 2 diabetesFinerenone significantly reduced the combined primary endpoint of chronic kidney disease progression, kidney failure or kidney death versus placebo when added to standard of care / Finerenone significantly reduced the combined key secondary endpoint of cardiovascular death or non-fatal cardiovascular events / Chronic kidney disease impacts 4 in 10 patients with type 2 diabetes and is a deadly condition that is underrecognized / Finerenone is the first investigational non-steroid...
Authors: Dutra JDM, Lisboa QC, Ferolla SM, Carvalho CMML, Mendes CCM, Ferrari TCA, Couto CA Abstract Some epidemiological evidence suggests an inverse correlation between non-alcoholic fatty liver disease (NAFLD) frequency and vitamin D levels. Likewise, a beneficial effect of vitamin D on diabetes mellitus (DM) and insulin resistance has been observed, but this is an unsolved issue. Thus, we aimed to investigate the prevalence of hypovitaminosis D in a NAFLD Brazilian population and its association with disease severity and presence of comorbidities. In a cross-sectional study, the clinical, biochemical and histo...
Publication date: Available online 9 July 2020Source: Nutrition, Metabolism and Cardiovascular DiseasesAuthor(s): Lucia La Sala, Livio Luzi, Antonio E. Pontiroli
Publication date: September–October 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &Reviews, Volume 14, Issue 5Author(s): Midhuna K, Prashant S. Adole, Kolar V. Vinod, N. Balamurugan
Publication date: Available online 9 July 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Shaikh Shahinur Rahman, Nilufar Yasmin, Md Kamruzzaman, Md Rezwanul Islam, Md Rezaul Karim, Shakh MA. Rouf
Publication date: Available online 9 July 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Manash Pratim Barman, Tousifur Rahman, Krishnarjun Bora, Chandan Borgohain
Publication date: Available online 8 July 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Ashish Kumar, Anil Arora, Praveen Sharma, Shrihari Anil Anikhindi, Naresh Bansal, Vikas Singla, Shivam Khare, Abhishyant Srivastava
Publication date: Available online 8 July 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Surabhi Mishra, Avinash Shetty, Chythra R. Rao, Sathisha Nayak, Asha Kamath